Article 49

TRANSITIONAL RESERVATIONS

1. A Party may at the time of signature, ratification or accession reserve the right to permit temporarily in any one of its territories:

(a) The quasi-medical use of opium;

(b) Opium smoking;

(c) Coca leaf chewing;

(d) The use of cannabis, cannabis resin, extracts and tinctures of cannabis for non-medical purposes; and

(e) The production and manufacture of and trade in the drugs referred to under (a) to (d) for the purposes mentioned therein.

2. The reservations under paragraph 1 shall be subject to the following restrictions:

(a) The activities mentioned in paragraph 1 may be authorized only to the extent that they were traditional in the territories in respect of which the reservation is made, and were there permitted on 1 January 1961.

(b) No export of the drugs referred to in paragraph 1 for the purposes mentioned therein may be permitted to a non-party or to a territory to which this Convention does not apply under article 42.

(c) Only such persons may be permitted to smoke opium as were registered by the competent authorities to this effect on 1 January 1964.

(d) The quasi-medical use of opium must be abolished within 15 years from the coming into force of this Convention as provided iparagraph 1 of article 41.

(e) Coca leaf chewing must be abolished within twenty-five years from the coming into force of this Convention as provided in paragraph 1 of article 41.

(f) The use of cannabis for other than medical and scientific purposes must be discontinued as soon as possible but in any case within twenty-five years from the coming into force of this Convention as provided in paragraph 1 of article 41.

(g) The production and manufacture of and trade in the drugs referred to in paragraph 1 for any of the uses mentioned therein must be reduced and finally abolished simultaneously with the reduction and abolition of such uses.

3. A Party making a reservation under paragraph 1 shall:
   
   

(a) Include in the annual report to be furnished to the Secretary-General, in accordance with article 18, paragraph 1 (a), an account of the progress made in the preceding year towards the abolition of the use, production, manufacture or trade referred to under paragraph 1; and

(b) Furnish to the Board separate estimates (article 19) and statistical returns (article 20) in respect of the reserved activities in the manner and form prescribed by the Board.

4. (a) If a Party which makes a reservation under paragraph 1 fails to furnish:

(i) The report referred to in paragraph 3 (a) within six months after the end of the year to which the information relates;

(ii) The estimates referred to in paragraph 3 (b) within three months after the date fixed for that purpose by the Board in accordance with article 12, paragraph 1;

(iii) The statistics referred to in paragraph 3 (b) within three months after the date on which they are due in accordance with article 20, paragraph 2, the Board or the Secretary-General, as the case may be, shall send to the Party concerned a notification of the delay, and shall request such information within a period of three months after the receipt of that notification.

(b) If the Party fails to comply within this period with the request of the Board or the Secretary-General, the reservation in question made under paragraph 1 shall cease to be effective,

5. A State which has made reservations may at any time by notification in writing withdraw all or part of its reservations.

Article 50

OTHER RESERVATIONS

1. No reservations other than those made in accordance with article 49 or with the following paragraphs shall be permitted.
2. Any State may at the time of signature, ratification or accession make reservations in respect of the following provisions of this Convention:
   Article 12, paragraphs 2 and 3; article 13, paragraph 2; article 14, paragraphs 1 and 2; article 31, paragraph 1 (b) and article 48.
3. A State which desires to become a Party but wishes to be authorized to make reservations other than those made in accordance with paragraph 2 of this article or with article 49 may inform the Secretary-General of such intention. Unless by the end of twelve months after the date of the Secretary-General's communication of the reservation concerned, this reservation has been objected to by one third of the States that have ratified or acceded to this Convention bethe end of that period, it shall be deemed to be permitted, it being understood however that States which have objected to the reservation need not assume towards the reserving State any legal obligation under this Convention which is affected by the reservation.
4. A State which has made reservations may at any time by notification in writing withdraw all or part of its reservations.

Article 51

NOTIFICATIONS

The Secretary-General shall notify to all the States referred to in paragraph 1 of article 40:

(a) Signatures, ratifications and accessions in accordance with article 40;

(b) The date upon which this Convention enters into force in accordance with article 41;

(c) Denunciations in accordance with article 46; and

(d) Declarations and notifications under articles 42, 43, 47, 49 and 50.

SCHEDULES

Revised Schedules including all amendments made by the Commission on Narcotic Drugs in Force as of 5 March 1990

List of Drugs Included in Schedule I

Acetorphine	3-O-acetyltetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno- oripavine
Acetyl-alpha-methylfentanyl	N-[1-(alpha-methylphenethyl)-4-piperidyl]acetanilide
Acetylmethadol	3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Alfentanil	N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4- piperidinyl]-N-phenylpropanamide
Allylprodine	3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine
Alphacetylmethadol	alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Alphameprodine	alpha-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine
Alphamethadol	alpha-6-dimethylamino-4,4-diphenyl-3-heptanol
Alpha-methylfentanyl	N-[1(alpha-methylphenethyl)-4-piperidyl]propionanilide
Alpha-methylthiofentanyl	N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
Alphaprodine	alpha-1,3-dimethyl-4-phenyl-4-propionoxypiperidine
Anileridine	1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
Benzethidine	1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
Benzylmorphine	3-O-benzylmorphine
Betacetylmethadol	beta-3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Beta-hydroxyfentanyl	N-[1-(beta-hydroxyphenethyl)-4-piperidyl]propionanilide
Beta-hydroxy-3-methylfentanyl	N-[1-(beta-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide
Betameprodine	beta-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine
Betamethadol	beta-6-dimethylamino-4,4-diphenyl-3-heptanol
Betaprodine	beta-1,3-dimethyl-4-phenyl-4-propionoxypiperidine
Bezitramide	1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)-piperidine
Cannabis and Cannabis resin	and EXTRACTS and TICTURES OF CANNABIS
Clonitazene	2-para-chlorbenzyl-1-diethylaminoethyl-5-nitrobenzimidazole
Coca leaf
Cocaine	methyl ester of benzoylecgonine
Codoxime	dihydrocodeinone-6-carboxymethyloxime
Concentrate of poppy straw	the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade
Desomorphine	dihydrodeoxymorphine
Dextromoramide	(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]-morpholine
Diampromide	N-[2-(methylphenethylamino)-propyl]propionanilide
Diethylthiambutene	3-diethylamino-1,1-di-(2 -thienyl)-1-butene
Difenoxin	1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid
Dihydromorphine
Dimenoxadol	2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate
Dimepheptanol	6-dimethylamino-4,4-diphenyl-3-heptanol
Dimethylthiambutene	3-dimethylamino-1,1-di-(2'-thienyl)-1-butene
Dioxaphetyl butyrate	ethyl-4-morpholino-2,2-diphenylbutyrate
Diphenoxylate	1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
Dipipanone	4,4-diphenyl-6-piperidine-3-heptanone
Drotebanol	3,4-dimethoxy-17-methylmorphinan-6-beta,14-diol
Ecgonine	its esters and derivatives which are convertible to ecgonine and cocaine
Ethylmethylthiambutene	3-ethylmethylamino-1,1-di-(2 -thienyl)-1-butene
Etonitazene	1-diethylaminoethyl-2-para-ethoxybenzyl-5-nitrobenzimidazole
Etorphine	tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine
Etoxeridine	1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester
Fentanyl	1-phenethyl-4-N-propionylanilinopiperidine
Furethidine	1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
Heroin	diacetylmorphine
Hydrocodone	dihydrocodeinone
Hydromorphinol	14-hydroxydihydromorphine
Hydromorphone	dihydromorphinone
Hydroxypethidine	4-meta-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester
Isomethadone	6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone
Ketobemidone	4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine
Levomethorphan*	(-)-3-methoxy-N-methylmorphinan
Levomoramide	(-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]morpholine
Levophenacylmorphan	(1)-3-hydroxy-N-phenacylmorphinan
Levorphanol *	(-)-3-hydroxy-N-methylmorphinan
Metazocine	2'-hydroxy-2,5,9-trimethyl-6,7-benzomorphan
Methadone	6-dimethylamino-4,4-diphenyl-3-heptanone
Methadone intermediate	4-cyano-2-dimethylamino-4,4-diphenylbutane
Methyldesorphine	6-methyl-delta-6-deoxymorphine
Methyldihydromorphine	6-methyldihydromorphine
3-methylfentanyl	N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide
3-methylthiofentanyl	N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
Metopon	5-methyldihydromorphinone
Moramide intermediate	2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid
Morpheridine	1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
Morphine
Morphine methobromide	and other pentavalent nitrogen morphine derivatives, including in particular the morphine-N-oxide derivatives, one of which is codeine-N-oxide
Morphine-N-oxide
MPPP	1-methyl-4-phenyl-4-piperidinol propionate (ester)
Myrophine	myristylbenzylmorphine
Nicomorphine	3,6-dinicotinylmorphine
Noracymethadol	( )-alpha-3-acetoxy-6-methylamino-4,4-diphenylheptane
Norlevorphanol	(-)-3-hydroxymorphinan
Normethadone	6-dimethylamino-4,4-diphenyl-3-hexanone
Normorphine	demethylmorphine or N-demethylated morphine
Norpipanone	4,4-diphenyl-6-piperidino-3-hexanone
Opium
Oxycodone	14-hydroxydihydrocodeinone
Oxymorphone	14-hydroxydihydromorphinone
Para-fluorofentanyl	4'-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide
PEPAP	1-phenethyl-4-phenyl-4-piperidinol acetate (ester)
Pethidine	1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
Pethidine intermediate A	4-cyano-1-methyl-4-phenylpiperidine
Pethidine intermediate B	4-phenylpiperidine-4-carboxylic acid ethyl ester
Pethidine intermediate C	1-methyl-4-phenylpiperidine-4-carboxylic acid
Phenadoxone	6-morpholino-4,4-diphenyl-3-heptanone
Phenampromide	N-(1-methyl-2-piperidinoethyl)-propionanilide
Phenazocine	2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan
Phenomorphan	3-hydroxy-N-phenethylmorphinan
Phenoperidine	1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
Piminodine	4-phenyl-1-(3-phenylaminopropyl)-piperidine-4-carboxylic acid ethyl ester
Piritramide	1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)-piperidine-4-carboxylic acid amide
Proheptazine	1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane
Properidine	1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester
Racemethorphan	( )-3-methoxy-N-methylmorphinan
Racemoramide	( )-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]-morpholin
Racemorphan	( )-3-hydroxy-N-methylmorphinan
Sufentanil	N-[4-(methoxymethyl)-1-[2-(2-thienyl)-ethyl]-4-piperidyl]propionanilide
Thebacon	acetyldihydrocodeinone
Thebaine
Thiofentanyl	N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
Tilidine	( )-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate
Trimeperidine	1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine; and

 

          The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;

          The esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule whenever the existence of such esters or ethers is possible;

          The salts of the drugs listed in this Schedule, including the salts of esters, ethers and isomers as provided above whenever the existence of such salts is possible.

* Dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan) are specifically excluded from this Schedule.

List of Drugs Included in Schedule II

Acetyldihydrocodeine
Codeine	3-O-methylmorphine
Dextropropoxyphene	alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate
Dihydrocodeine
Ethylmorphine	3-O-ethylmorphine
Nicocodine	6-nicotinylcodeine
Nicodicodine	6-nicotinyldihydrocodeine
Norcodeine	N-demethylcodeine
Pholcodine	Morpholinylethylmorphine
Propiram	N-(1-methyl-2-piperidinoethyl)-N-2-; and

          The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;

          The salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible.

List of Preparations Included in Schedule III

1. Preparations of	Acetyldihydrocodeine,
	Codeine,
	Dihydrocodeine,
	Ethylmorphine,
	Nicodicodine,
	Norcodeine, and
	Pholcodine

when compounded with one or more other ingredients and containing not more than 100 milligrams of the drug per dosage unit and with a concentration of not more than 2.5 per cent in undivided preparations.

2. Preparations of Propiram containing not more than 100 milligrams of propiram per dosage unit and compounded with at least the same amount of methylcellulose.

3. Preparations of Dextropropoxyphene for oral use containing not more than 135 milligrams of dextropropoxyphene base per dosage unit or with a concentration of not more than 2.5 per cent in undivided preparations, provided that such preparations do not contain any substance controlled under the 1971 Convention on Psychotropic Substances.

4. Preparations of Cocaine containing not more than 0.1 per cent of cocaine calculated as cocaine base and preparations of opium or morphine containing not more than 0.2 per cent of morphine calculated as anhydrous morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.

5. Preparations of Difenoxin containing, per dosage unit, not more than 0.5 milligram of difenoxin and a quantity of atropine sulfate equivalent to at least 5 per cent of the dose of difenoxin.

6. Preparations of Diphenoxylate containing, per dosage unit, not more than 2.5 milligrams of diphenoxylate calculated as base and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose of diphenoxylate.

7. Preparations of Pulvis ipecacuanhae et opii compositus

10 per cent opium in powder,
10 per cent ipecacuanha root, in powder well mixed with
80 per cent of any other powdered ingredient containing no drug.

8. Preparations conforming to any of the formulas listed in this Schedule and mixtures of such preparations with any material which contains no drug.

List of Drugs Included in Schedule IV

Acetorphine	3-O-acetyltetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine
Acetyl-alpha-methylfentanyl	N-[1-(alpha-methylphenethyl)-4-piperidyl]acetanilide
Alpha-methylfentanyl	N-[1-(alpha-methylphenethyl)-4-piperidyl]propionanilide
Alpha-methylthiofentanyl	N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
Beta-hydroxy-3-methylfentanyl	N-[1-(beta-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide
Beta-hydroxyfentanyl	N-[1-(beta-hydroxyphenethyl)-4-piperidyl]propionanilide
Cannabis and Cannabis resin
Desomorphine	Dihydrodeoxymorphine
Etorphine	tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine
Heroin	Diacetylmorphine
Ketobemidone	4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine
3-methylfentanyl	N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide; cis-N-[3-methyl-1(2-phenylethyl)-4-piperidyl]propionanilide; trans-N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]propionanilide
3-methylthiofentanyl	N-(3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
MPPP	1-methyl-4-phenyl-4-piperidinol propionate (ester)
Para-fluorofentanyl	4'-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide
PEPAP	1-phenethyl-4-phenyl-4-piperidinol acetate (ester)
Thiofentanyl	N-[1-[2-(thienyl)ethyl]-4-piperidyl]propionanilide; and

          The salts of the drugs listed in this Schedule whenever the formation of such salts is possible.